Lung Cancer

Extensive Lymph Node, Node Station Dissection Recommended in Pure-Solid NSCLC

By

Leah Lawrence

Publish Date May 14, 2021

Greater examination aided in accurate staging and improved survival in pure-solid, non-small cell lung cancer.

Bone Metastases Lower Overall Survival in mNSCLC Treated With ICIs

By

Leah Lawrence

Publish Date May 14, 2021

Bone modifying agents had no effect on survival outcomes.

Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward

By

Colby Stong

Publish Date May 5, 2021

The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.

Olanzapine Substitution Effective in Triple Therapy for Carboplatin-Induced CINV

By

Jessica Nye, PhD

Publish Date April 22, 2021

Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.

A Brief Guide to Common Adverse Events Related to Tepotinib Therapy for METex14 Skipping NSCLC

By

Jessica Nye, PhD

Publish Date April 21, 2021

Guidance for early identification and effective management strategies for adverse effects related to tepotinib therapy in patients with METex14 skipping NSCLC are presented in a poster at ONS Congress 2021.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)